Cue Health Geçmiş Kazanç Performansı
Hala bu şirketin son kazanç raporunu inceliyoruz
Geçmiş kriter kontrolleri 0/6
Cue Health's earnings have been declining at an average annual rate of -73.7%, while the Medical Equipment industry saw earnings growing at 9.8% annually. Revenues have been growing at an average rate of 1% per year.
Anahtar bilgiler
-73.7%
Kazanç büyüme oranı
-6.2%
EPS büyüme oranı
| Medical Equipment Sektör Büyümesi | 8.9% |
| Gelir büyüme oranı | 1.0% |
| Özkaynak getirisi | -149.2% |
| Net Marj | -526.5% |
| Son Kazanç Güncellemesi | 31 Dec 2023 |
Yakın geçmiş performans güncellemeleri
Recent updates
Take Care Before Jumping Onto Cue Health Inc. (NASDAQ:HLTH) Even Though It's 26% Cheaper
May 10
Investors Don't See Light At End Of Cue Health Inc.'s (NASDAQ:HLTH) Tunnel And Push Stock Down 26%
Mar 22Cue Health Inc.'s (NASDAQ:HLTH) Price Is Right But Growth Is Lacking After Shares Rocket 31%
Jan 28We're A Little Worried About Cue Health's (NASDAQ:HLTH) Cash Burn Rate
Jan 06Investors Don't See Light At End Of Cue Health Inc.'s (NASDAQ:HLTH) Tunnel And Push Stock Down 28%
Nov 10These Analysts Think Cue Health Inc.'s (NASDAQ:HLTH) Sales Are Under Threat
Aug 14Can Cue Health (NASDAQ:HLTH) Afford To Invest In Growth?
Jul 12Revenue Downgrade: Here's What Analysts Forecast For Cue Health Inc. (NASDAQ:HLTH)
May 15Cue Health Inc. (NASDAQ:HLTH) Analysts Just Slashed This Year's Revenue Estimates By 56%
Mar 21We Think Cue Health (NASDAQ:HLTH) Needs To Drive Business Growth Carefully
Mar 12Cue Health Inc.'s (NASDAQ:HLTH) Intrinsic Value Is Potentially 44% Above Its Share Price
Feb 13Cue Health Inc. (NASDAQ:HLTH) Analysts Just Trimmed Their Revenue Forecasts By 24%
Nov 18Here's Why We're Not Too Worried About Cue Health's (NASDAQ:HLTH) Cash Burn Situation
Oct 30Cue Health applies for FDA emergency use nod for its flu & COVID-19 molecular test
Oct 04Cue Health appoints chief medical oficer
Sep 08Gelir ve Gider Dağılımı
Cue Health nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.
Kazanç ve Gelir Geçmişi
| Tarih | Gelir | Kazançlar | G+A Giderleri | Ar-Ge Giderleri |
|---|---|---|---|---|
| 31 Dec 23 | 71 | -373 | 90 | 0 |
| 30 Sep 23 | 199 | -257 | 112 | 0 |
| 30 Jun 23 | 251 | -276 | 133 | 0 |
| 31 Mar 23 | 329 | -291 | 153 | 0 |
| 31 Dec 22 | 483 | -194 | 186 | 0 |
| 30 Sep 22 | 529 | -138 | 192 | 0 |
| 30 Jun 22 | 683 | -67 | 187 | 0 |
| 31 Mar 22 | 733 | 34 | 157 | 0 |
| 31 Dec 21 | 618 | 33 | 109 | 0 |
| 30 Sep 21 | 439 | -11 | 72 | 0 |
| 30 Jun 21 | 220 | -24 | 37 | 0 |
| 31 Mar 21 | 87 | -37 | 27 | 0 |
| 31 Dec 20 | 23 | -47 | 25 | 0 |
| 31 Dec 19 | 7 | -21 | 6 | 0 |
Kaliteli Kazançlar: HLTH is currently unprofitable.
Büyüyen Kar Marjı: HLTH is currently unprofitable.
Serbest Nakit Akışı ve Kazanç Analizi
Geçmiş Kazanç Büyüme Analizi
Kazanç Eğilimi: HLTH is unprofitable, and losses have increased over the past 5 years at a rate of 73.7% per year.
Büyüme Hızlandırma: Unable to compare HLTH's earnings growth over the past year to its 5-year average as it is currently unprofitable
Kazançlar vs. Sektör: HLTH is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (2.3%).
Özkaynak Getirisi
Yüksek ROE: HLTH has a negative Return on Equity (-149.24%), as it is currently unprofitable.